JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hirota, K.
Right arrow Articles by Lambert, D. G.
Related Collections
Right arrow Pharmacology

Anesth Analg 2002;95:1607-1610
© 2002 International Anesthesia Research Society

ANESTHETIC PHARMACOLOGY

Interaction of Intravenous Anesthetics with Recombinant Human M1-M3 Muscarinic Receptors Expressed in Chinese Hamster Ovary Cells

Kazuyoshi Hirota, MD*, Yoshio Hashimoto, MD*, and David G. Lambert, PhD{dagger}

*Department of Anesthesiology, University of Hirosaki School of Medicine, Hirosaki, Japan; and {dagger}University Department of Anaesthesia, Critical Care and Pain Management, Leicester Royal Infirmary, Leicester, United Kingdom

Address correspondence and reprint requests to David G. Lambert, PhD, Address e-mail to DGL3{at}le.ac.uk

Previous reports suggest that the effects of propofol, ketamine, and thiopental on airway tone may be because of modulation of parasympathetic activity. We examined if these anesthetics interact with recombinant human M1-M3 muscarinic receptors expressed in Chinese hamster ovary cells (CHO-M1, M2, and M3) using the displacement of 0.4 nM of l-[N-methyl-3H]scopolamine methyl chloride([3H]NMS). In addition, functional studies were performed by fluorometrically monitoring methacholine (1 mM) stimulated intracellular Ca2+ ([Ca2+]i) responses. Ketamine concentration dependently displaced [3H]NMS binding to CHO-M1, M2, and M3 cells with affinity, pKi (mean Ki) values of 4.34 ± 0.14 (45 µM), 3.53 ± 0.10 (294 µM), and 3.61 ± 0.02 (246 µM), respectively. The effects at M1 were in the clinical range. Ketamine did not affect either basal or methacholine stimulated increase in [Ca2+]i in CHO-M1 cells. Thiopental significantly displaced [3H]NMS binding to M3 (pKi [mean Ki] = 4.12 ± 0.06 [75 µM]) but not M1 or M2 receptors. Thiopental (10-5–10-3 M) concentration dependently inhibited methacholine stimulated increase in [Ca2+]i in CHO-M3 cells. Propofol and barbituric acid did not interact with any muscarinic receptor subtype. We suggest that at the level of [Ca2+]I, thiopental may possess M3 antagonist activity, whereas there are no functional consequences of the interaction of ketamine with the M1 receptor.

IMPLICATIONS: In this study using recombinant human M1-M3 muscarinic receptors, we show that for agonist-stimulated increases in intracellular Ca2+ thiopental acts as a M3 antagonist.






Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2002 by the International Anesthesia Research Society.